NYSE:NUS - Nu Skin Enterprises Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$76.11 -1.17 (-1.51 %)
(As of 07/16/2018 11:55 AM ET)
Previous Close$77.21
Today's Range$75.99 - $77.21
52-Week Range$53.50 - $84.00
Volume7,558 shs
Average Volume359,929 shs
Market Capitalization$4.30 billion
P/E Ratio22.93
Dividend Yield1.89%
Nu Skin Enterprises logoNu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples


Debt-to-Equity Ratio0.13
Current Ratio1.14
Quick Ratio0.75


Trailing P/E Ratio22.93
Forward P/E Ratio21.44
P/E Growth2.37

Sales & Book Value

Annual Sales$2.28 billion
Price / Sales1.86
Cash Flow$4.6579 per share
Price / Cash16.34
Book Value$13.40 per share
Price / Book5.68


EPS (Most Recent Fiscal Year)$3.23
Net Income$129.43 million
Net Margins5.74%
Return on Equity25.36%
Return on Assets11.54%


Outstanding Shares55,610,000
Market Cap$4,297.62

The Truth About Cryptocurrencies

Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises declared a quarterly dividend on Friday, April 27th. Investors of record on Friday, May 25th will be given a dividend of $0.365 per share on Wednesday, June 13th. This represents a $1.46 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date of this dividend is Thursday, May 24th. View Nu Skin Enterprises' Dividend History.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) issued its quarterly earnings results on Thursday, April, 26th. The company reported $0.79 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.70 by $0.09. The company had revenue of $616 million for the quarter, compared to the consensus estimate of $564.46 million. Nu Skin Enterprises had a return on equity of 25.36% and a net margin of 5.74%. The company's quarterly revenue was up 23.4% on a year-over-year basis. During the same quarter last year, the business earned $0.51 EPS. View Nu Skin Enterprises' Earnings History.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Nu Skin Enterprises.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share (EPS) guidance of $3.73-3.93 for the period, compared to the Thomson Reuters consensus estimate of $3.61. The company issued revenue guidance of $2.51-2.56 billion, compared to the consensus revenue estimate of $2.47 billion.Nu Skin Enterprises also updated its Q2 guidance to $0.91-0.96 EPS.

What price target have analysts set for NUS?

5 brokers have issued 1 year target prices for Nu Skin Enterprises' stock. Their forecasts range from $57.00 to $98.00. On average, they anticipate Nu Skin Enterprises' stock price to reach $80.80 in the next twelve months. This suggests a possible upside of 6.2% from the stock's current price. View Analyst Ratings for Nu Skin Enterprises.

What is the consensus analysts' recommendation for Nu Skin Enterprises?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

What are Wall Street analysts saying about Nu Skin Enterprises stock?

Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
  • 1. According to Zacks Investment Research, "Nu Skin has seen its shares decline and underperform the industry in the past month. The company has been struggling with declining gross margins for a while, thanks to lower margins from acquired businesses. This remains a threat. Moreover, the company remains exposed to significant currency risks stemming from international markets and stiff competition from the existence of strong peers and abundant product alternatives. Nonetheless, the company’s top line has been consistently benefitting from growth in sales leaders. During the first quarter of 2018, sales leaders improved approximately 16% and customer base increased 7%. During the quarter, revenues grew in all regional segments. To sustain such solid trends, Nu Skin remains on track with initiatives to enhance technological capabilities along with well-knit product launches and marketing programs." (7/2/2018)
  • 2. Pivotal Research analysts commented, "We think 2018 might be bigger than usual – for Repo which again, is not in guidance." (2/16/2018)

Who are some of Nu Skin Enterprises' key competitors?

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the folowing people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 65)
  • Mr. Ritch N. Wood, CEO & Director (Age 52)
  • Mr. Ryan S. Napierski, Pres (Age 44)
  • Mr. Mark H. Lawrence, Exec. VP & CFO
  • Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 65)

Has Nu Skin Enterprises been receiving favorable news coverage?

Press coverage about NUS stock has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nu Skin Enterprises earned a news impact score of 0.09 on Accern's scale. They also gave media stories about the company an impact score of 48.13 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a number of of retail and institutional investors. Top institutional investors include Columbia Partners L L C Investment Management (0.07%), State of Alaska Department of Revenue (0.01%), Campbell & CO Investment Adviser LLC (0.01%) and Clinton Group Inc. (0.01%). Company insiders that own Nu Skin Enterprises stock include Andrew D Lipman, D Matthew Dorny, Daniel W Campbell, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.

Which institutional investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including Columbia Partners L L C Investment Management and Campbell & CO Investment Adviser LLC. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, Daniel W Campbell, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Insider Buying and Selling for Nu Skin Enterprises.

Which institutional investors are buying Nu Skin Enterprises stock?

NUS stock was purchased by a variety of institutional investors in the last quarter, including Clinton Group Inc. and State of Alaska Department of Revenue. View Insider Buying and Selling for Nu Skin Enterprises.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $76.11.

How big of a company is Nu Skin Enterprises?

Nu Skin Enterprises has a market capitalization of $4.30 billion and generates $2.28 billion in revenue each year. The company earns $129.43 million in net income (profit) each year or $3.23 on an earnings per share basis. Nu Skin Enterprises employs 4,700 workers across the globe.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]

MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  377 (Vote Outperform)
Underperform Votes:  345 (Vote Underperform)
Total Votes:  722
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.